Related references
Note: Only part of the references are listed.YBX1 regulated by Runx3-miR-148a-3p axis facilitates non-small-cell lung cancer progression
Hongbo Su et al.
CELLULAR SIGNALLING (2021)
RUNX3 suppresses metastasis and stemness by inhibiting Hedgehog signaling in colorectal cancer
Bo Ram Kim et al.
CELL DEATH AND DIFFERENTIATION (2020)
Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome
Takako Yokomizo-Nakano et al.
CANCER RESEARCH (2020)
ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias
Miroslav Boudny et al.
CANCER TREATMENT REVIEWS (2020)
Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets
Xuanrong Chen et al.
NPJ PRECISION ONCOLOGY (2020)
Genetic and epigenetic determinants of AML pathogenesis
Sheng F. Cai et al.
SEMINARS IN HEMATOLOGY (2019)
Super-enhancers: critical roles and therapeutic targets in hematologic malignancies
Yunlu Jia et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
IKZF2 Drives Leukemia Stem Cell Self-Renewal and Inhibits Myeloid Differentiation
Sun-Mi Park et al.
CELL STEM CELL (2019)
Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models
Waleed Minzel et al.
CELL (2018)
A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia
Haley E. Ramsey et al.
CANCER DISCOVERY (2018)
Genomics of Acute Myeloid Leukemia Diagnosis and Pathways
Lars Bullinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC
V. Selvarajan et al.
LEUKEMIA (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
RUNX transcription factors at the interface of stem cells and cancer
Elitza Deltcheva et al.
BIOCHEMICAL JOURNAL (2017)
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase
Zejuan Li et al.
CANCER CELL (2017)
The emerging role of RUNX3 in cancer metastasis
Feifei Chen et al.
ONCOLOGY REPORTS (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Acute myeloid leukaemia
Asim Khwaja et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia
Masayuki Iwasaki et al.
CELL STEM CELL (2015)
Sox4 Is a Key Oncogenic Target in C/EBPα Mutant Acute Myeloid Leukemia
Hong Zhang et al.
CANCER CELL (2013)
Runx3 Inactivation Is a Crucial Early Event in the Development of Lung Adenocarcinoma
You-Soub Lee et al.
CANCER CELL (2013)
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz et al.
CELL (2013)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
RUNX3 functions as an oncogene in ovarian cancer
Cecilia Wei Lin Lee et al.
GYNECOLOGIC ONCOLOGY (2011)
Oncogenic Role of RUNX3 in Head and Neck Cancer
Yasusei Kudo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
RUNX3 is multifunctional in carcinogenesis of multiple solid tumors
L. S. H. Chuang et al.
ONCOGENE (2010)
DDB1-CUL4 and MLL1 Mediate Oncogene-Induced p16INK4a Activation
Yojiro Kotake et al.
CANCER RESEARCH (2009)
Transcriptional repression of the RUNX3/AML2 gene by the t(8;21) and inv(16) fusion proteins in acute myeloid leukemia
Chi Keung Cheng et al.
BLOOD (2008)
RUNX3 protein is overexpressed in human basal cell carcinomas
M. Salto-Tellez et al.
ONCOGENE (2006)
RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors
WJ Kim et al.
CANCER RESEARCH (2005)
Causal relationship between the loss of RUNX3 expression and gastric cancer
QL Li et al.
CELL (2002)
The RUNX3 gene -: sequence, structure and regulated expression
C Bangsow et al.
GENE (2001)